Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
Noriho SakamotoHiroshi IshimotoShota NakashimaHirokazu YuraTakuto MiyamuraDaisuke OkunoAtsuko HaraTakeshi KitazakiTomoyuki KakugawaYuji IshimatsuMinoru SatohHiroshi Mukae
著者情報
ジャーナル オープンアクセス

2019 年 58 巻 6 号 p. 837-841

詳細
抄録

Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with rapidly progressive interstitial lung disease (RP-ILD) in patients with clinically amyopathic dermatomyositis (CADM) or dermatomyositis (DM). We herein report three Japanese cases of anti-MDA5 antibody-positive RP-ILD without signs of CADM or DM. High-resolution computed tomography revealed patchy or subpleural distribution of consolidations and/or ground-glass opacities accompanied by traction bronchiectasis. All patients succumbed to respiratory failure within two months. Anti-MDA5 antibody-positive RP-ILD without signs of CADM or DM should be included in the differential diagnosis of acute/subacute ILD. Measurement of anti-MDA5 antibody and an intensive immunosuppressive regimen might rescue these patients from RP-ILD.

著者関連情報
© 2019 by The Japanese Society of Internal Medicine
前の記事 次の記事
feedback
Top